Active Ingredient(s):Bupivacaine + Meloxicam FDA Approved: * May 12, 2021 Pharm Company: *Heron Therapeutics, Inc. Category:Anesthetic
Bupivacaine/meloxicam, sold under the brand name Zynrelef, is a fixed-dose combination medication used to treat pain in small to medium-sized wounds after surgery.[1][2][3] It contains bupivacaine and meloxicam.[1][2]
The most common side effects of bupivacaine/meloxicam are dizziness, constipation, vomiting, and headache.[1][2]
It was approved for medical use in the European Union ...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.
